Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CCDC13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCDC13 mRNA | CTD | PMID:21570461 | CCDC13 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCDC13 mRNA | CTD | PMID:33387578 | CCDC13 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of CCDC13 mRNA | CTD | PMID:37199045 | CCDC13 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Ccdc13 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of CCDC13 exon | CTD | PMID:33297965 | CCDC13 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ccdc13 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CCDC13 gene | CTD | PMID:31683443 | CCDC13 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CCDC13 5' UTR | CTD | PMID:27901495 | CCDC13 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CCDC13 3' UTR | CTD | PMID:27901495 | CCDC13 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of CCDC13 exon and Benzo(a)pyrene results in decreased methylation of CCDC13 promoter | CTD | PMID:27901495 | CCDC13 | Human | bisphenol A | decreases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CCDC13 mRNA | CTD | PMID:25181051 | CCDC13 | Human | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CCDC13 gene | CTD | PMID:31601247 | CCDC13 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CCDC13 gene | CTD | PMID:31601247 | CCDC13 | Human | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of CCDC13 mRNA | CTD | PMID:26079696 | CCDC13 | Human | carbon nanotube | decreases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CCDC13 | Human | chlorpyrifos | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CCDC13 mRNA | CTD | PMID:37019170 | CCDC13 | Human | Cuprizon | decreases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of CCDC13 mRNA | CTD | PMID:26577399 and PMID:27523638 | CCDC13 | Human | dextran sulfate | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of CCDC13 mRNA | CTD | PMID:35093514 | CCDC13 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CCDC13 mRNA | CTD | PMID:28302478 | CCDC13 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CCDC13 | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of CCDC13 mRNA | CTD | PMID:26272509 | CCDC13 | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCDC13 mRNA | CTD | PMID:27188386 | CCDC13 | Human | fenvalerate | increases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of CCDC13 mRNA | CTD | PMID:30307764 | CCDC13 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CCDC13 gene | CTD | PMID:31601247 | CCDC13 | Human | gentamycin | increases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of CCDC13 mRNA | CTD | PMID:33387578 | CCDC13 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of CCDC13 mRNA | CTD | PMID:33647349 | CCDC13 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CCDC13 mRNA | CTD | PMID:35430440 | CCDC13 | Human | paracetamol | increases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CCDC13 mRNA | CTD | PMID:33387578 | CCDC13 | Human | pentachlorophenol | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of CCDC13 mRNA | CTD | PMID:23892564 | CCDC13 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of CCDC13 mRNA | CTD | PMID:26079696 | CCDC13 | Human | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of CCDC13 mRNA | CTD | PMID:26272509 | CCDC13 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CCDC13 mRNA | CTD | PMID:27188386 | CCDC13 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CCDC13 | Human | sodium arsenite | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CCDC13 mRNA | CTD | PMID:37682722 | CCDC13 | Human | sodium fluoride | decreases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of CCDC13 protein | CTD | PMID:28918527 | CCDC13 | Human | sodium fluoride | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of CCDC13 mRNA | CTD | PMID:27862939 | CCDC13 | Human | sulforaphane | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | sulforaphane results in increased expression of CCDC13 mRNA | CTD | PMID:30529165 | CCDC13 | Human | titanium dioxide | affects expression | ISO | Ccdc13 (Mus musculus) | 6480464 | titanium dioxide affects the expression of CCDC13 mRNA | CTD | PMID:23557971 | CCDC13 | Human | trichloroethene | increases expression | ISO | Ccdc13 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CCDC13 mRNA | CTD | PMID:33387578 | CCDC13 | Human | triptonide | increases expression | ISO | Ccdc13 (Mus musculus) | 6480464 | triptonide results in increased expression of CCDC13 mRNA | CTD | PMID:33045310 | CCDC13 | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of CCDC13 mRNA | CTD | PMID:29024780 | |